​APHL Member Access Restrictions: A number of resources on this page can only be accessed by APHL members, and you must be signed in to view them. If you have access, please do not distribute them beyond the public health laboratory community. If you need additional materials or would like to request access, please contact eoc@aphl.org​​.​

APHL/CDC Public Health Laboratory Call Summaries and APHL Lab Alerts
(APHL Member Access Only, Sign-in Required)

 

COVID-19 Test Characteristics

With the ever-expanding number of COVID-19 tests available, it can be difficult to compare them and determine which are best suited for your use. To assist with this effort, APHL has compiled a list of many molecular tests and their key characteristics, such as the specimen type(s) they support, performance, platform footprint and lab vs POC use.

Below are brief summaries of a select number of tests; an expanded list can be viewed online or downloaded.

Note: To facilitate the selection of the proper standard codes when reporting the results of these tests CDC has published a LOINC to IVD Mapping tool. Learn more about this tool in the "Informatics HL7 Messaging" section, above.

  
  
  
Throughput
CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel (CDC)Centers for Disease Control and PreventionHigh

21-22 specimens/5 hr

cobas® SARS-CoV-2Roche Molecular Systems, Inc. (RMS)High

6800: 384 specimens/8 hr

8800: 1,056 specimens/8 hr

TaqPath™ COVID-19 Combo KitThermo Fisher Scientific, Inc.High

94 specimens/3 hr

382 specimens/6.5 hr

Panther Fusion® SARS-CoV-2 AssayHologic®, Inc.High

1,150 specimens/24 hr

Abbott RealTime SARS-CoV-2 assayAbbott MolecularHigh

470 specimens/24 hr

Page Last Reviewed: July 8, 2020